Literature DB >> 36070094

[Neurofibromatosis type 1 : From diagnosis to follow-up].

Rebecca Anders1, Franz Wolfgang Hirsch1, Christian Roth2.   

Abstract

BACKGROUND: Neurofibromatosis type 1 (NF1) is a tumor predisposition syndrome and is one of the most common genetic diseases. It is therefore a condition encountered by radiologists in clinical routine. Since the variability of the clinical expression is very high and several organ systems are affected, we present a standardized diagnostic approach in this article.
METHODS: Evaluation of the literature on neurofibromatosis type 1 in the context of radiological examination methods.
RESULTS: In addition to the frequently known changes in the central and peripheral nervous system such as optic gliomas and plexiform neurofibromas, lesions from the orthopedic spectrum and vascular changes must also be included in the radiological diagnosis.
CONCLUSIONS: Due to the diversity of the clinical picture of NF1, it is reasonable to define an examination strategy which takes into account the needs of radiological routine and also reliably detects the most frequent and prognostically significant pathologies accompanying this disease. In this article, the current recommendations for diagnosis of neurofibromatosis-associated tumors and skeletal changes are summarized, and examination protocols and time intervals are suggested.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Genetic predisposition; Magnetic resonance imaging; Neurofibroma; Optic glioma; Recommendations

Year:  2022        PMID: 36070094     DOI: 10.1007/s00117-022-01059-7

Source DB:  PubMed          Journal:  Radiologie (Heidelb)        ISSN: 2731-7048


  34 in total

1.  Focal Areas of High Signal Intensity in Children with Neurofibromatosis Type 1: Expected Evolution on MRI.

Authors:  S Calvez; R Levy; R Calvez; C-J Roux; D Grévent; Y Purcell; K Beccaria; T Blauwblomme; J Grill; C Dufour; F Bourdeaut; F Doz; M P Robert; N Boddaert; V Dangouloff-Ros
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-13       Impact factor: 3.825

Review 2.  Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.

Authors:  Peter M K de Blank; Michael J Fisher; Grant T Liu; David H Gutmann; Robert Listernick; Rosalie E Ferner; Robert A Avery
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

3.  Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential?

Authors:  P D Griffiths; S Blaser; W Mukonoweshuro; D Armstrong; G Milo-Mason; S Cheung
Journal:  Pediatrics       Date:  1999-10       Impact factor: 7.124

4.  Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

Authors:  S M Huson; P S Harper; D A Compston
Journal:  Brain       Date:  1988-12       Impact factor: 13.501

5.  Neurofibromatosis types 1 and 2: cranial MR findings.

Authors:  S Aoki; A J Barkovich; K Nishimura; B O Kjos; T Machida; P Cogen; M Edwards; D Norman
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

Review 6.  Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.

Authors:  Reinhard E Friedrich; Michael A Nuding
Journal:  Anticancer Res       Date:  2016-08       Impact factor: 2.480

7.  Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours.

Authors:  S Cardona; M Schwarzbach; Ulf Hinz; A Dimitrakopoulou-Strauss; N Attigah; G Mechtersheimer section sign; T Lehnert
Journal:  Eur J Surg Oncol       Date:  2003-08       Impact factor: 4.424

Review 8.  [Spinal deformity in neurofibromatosis type 1].

Authors:  Christoph-E Heyde; A Völker; N H von der Höh; S Glasmacher; H Koller
Journal:  Orthopade       Date:  2021-07-08       Impact factor: 1.087

9.  Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.

Authors:  Christina Bergqvist; Amandine Servy; Laurence Valeyrie-Allanore; Salah Ferkal; Patrick Combemale; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.